Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.15 AUD 3.45% Market Closed
Market Cap: 43.8m AUD
Have any thoughts about
Next Science Ltd?
Write Note

Intrinsic Value

NXS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one NXS stock under the Base Case scenario is 1.46 AUD. Compared to the current market price of 0.15 AUD, Next Science Ltd is Undervalued by 90%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NXS Intrinsic Value
1.46 AUD
Undervaluation 90%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Next Science Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NXS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NXS?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Next Science Ltd

Provide an overview of the primary business activities
of Next Science Ltd.

What unique competitive advantages
does Next Science Ltd hold over its rivals?

What risks and challenges
does Next Science Ltd face in the near future?

Has there been any significant insider trading activity
in Next Science Ltd recently?

Summarize the latest earnings call
of Next Science Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Next Science Ltd.

Provide P/S
for Next Science Ltd.

Provide P/E
for Next Science Ltd.

Provide P/OCF
for Next Science Ltd.

Provide P/FCFE
for Next Science Ltd.

Provide P/B
for Next Science Ltd.

Provide EV/S
for Next Science Ltd.

Provide EV/GP
for Next Science Ltd.

Provide EV/EBITDA
for Next Science Ltd.

Provide EV/EBIT
for Next Science Ltd.

Provide EV/OCF
for Next Science Ltd.

Provide EV/FCFF
for Next Science Ltd.

Provide EV/IC
for Next Science Ltd.

Show me price targets
for Next Science Ltd made by professional analysts.

What are the Revenue projections
for Next Science Ltd?

How accurate were the past Revenue estimates
for Next Science Ltd?

What are the Net Income projections
for Next Science Ltd?

How accurate were the past Net Income estimates
for Next Science Ltd?

What are the EPS projections
for Next Science Ltd?

How accurate were the past EPS estimates
for Next Science Ltd?

What are the EBIT projections
for Next Science Ltd?

How accurate were the past EBIT estimates
for Next Science Ltd?

Compare the revenue forecasts
for Next Science Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Next Science Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Next Science Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Next Science Ltd compared to its peers.

Compare the P/E ratios
of Next Science Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Next Science Ltd with its peers.

Analyze the financial leverage
of Next Science Ltd compared to its main competitors.

Show all profitability ratios
for Next Science Ltd.

Provide ROE
for Next Science Ltd.

Provide ROA
for Next Science Ltd.

Provide ROIC
for Next Science Ltd.

Provide ROCE
for Next Science Ltd.

Provide Gross Margin
for Next Science Ltd.

Provide Operating Margin
for Next Science Ltd.

Provide Net Margin
for Next Science Ltd.

Provide FCF Margin
for Next Science Ltd.

Show all solvency ratios
for Next Science Ltd.

Provide D/E Ratio
for Next Science Ltd.

Provide D/A Ratio
for Next Science Ltd.

Provide Interest Coverage Ratio
for Next Science Ltd.

Provide Altman Z-Score Ratio
for Next Science Ltd.

Provide Quick Ratio
for Next Science Ltd.

Provide Current Ratio
for Next Science Ltd.

Provide Cash Ratio
for Next Science Ltd.

What is the historical Revenue growth
over the last 5 years for Next Science Ltd?

What is the historical Net Income growth
over the last 5 years for Next Science Ltd?

What is the current Free Cash Flow
of Next Science Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Next Science Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Next Science Ltd

Current Assets 8.2m
Cash & Short-Term Investments 3.6m
Receivables 3.2m
Other Current Assets 1.3m
Non-Current Assets 3.6m
PP&E 1.3m
Intangibles 2.3m
Other Non-Current Assets 36.7k
Current Liabilities 3.8m
Accounts Payable 3.1m
Accrued Liabilities 132.4k
Other Current Liabilities 531k
Non-Current Liabilities 987.7k
Long-Term Debt 569k
Other Non-Current Liabilities 418.8k
Efficiency

Earnings Waterfall
Next Science Ltd

Revenue
23.3m USD
Cost of Revenue
-4.9m USD
Gross Profit
18.4m USD
Operating Expenses
-31.9m USD
Operating Income
-13.6m USD
Other Expenses
67.6k USD
Net Income
-13.5m USD

Free Cash Flow Analysis
Next Science Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NXS Profitability Score
Profitability Due Diligence

Next Science Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
28/100
Profitability
Score

Next Science Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

NXS Solvency Score
Solvency Due Diligence

Next Science Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
59/100
Solvency
Score

Next Science Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NXS Price Targets Summary
Next Science Ltd

Wall Street analysts forecast NXS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NXS is 0.34 AUD with a low forecast of 0.27 AUD and a high forecast of 0.42 AUD.

Lowest
Price Target
0.27 AUD
82% Upside
Average
Price Target
0.34 AUD
128% Upside
Highest
Price Target
0.42 AUD
180% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NXS?

Click here to dive deeper.

Dividends

Next Science Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for NXS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NXS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Next Science Ltd Logo
Next Science Ltd

Country

Australia

Industry

Health Care

Market Cap

43.8m AUD

Dividend Yield

0%

Description

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

Contact

NEW SOUTH WALES
Chatswood
Tower B, The Zenith L 19, 821 Pacific Highway
+61286075124.0
www.nextscience.com

IPO

2019-04-18

Employees

-

Officers

MD, CEO & Director
Mr. Harry Thomas Hall
Founder & CTO
Dr. Matthew Franco Myntti
Chief Financial Officer
Marc Zimmerman
Chief Operating Officer
Mr. Jon Swanson
Senior Vice President of North American Sales
Mr. Robert Bell
Company Secretary
Ms. Gillian Maria Nairn AGIA, B.A., BA, L.L.B., L.L.M., LLB, LLM, MAICD

See Also

Discover More
What is the Intrinsic Value of one NXS stock?

The intrinsic value of one NXS stock under the Base Case scenario is 1.46 AUD.

Is NXS stock undervalued or overvalued?

Compared to the current market price of 0.15 AUD, Next Science Ltd is Undervalued by 90%.

Back to Top